

25 Sep 2026 · 2m · 1 chapter

Oracle’s New Mexico AI data-center project faces power, permitting, and local resistance; Novo Nordisk’s deal for drug-delivery tech; and climate-tech venture capital shifting toward AI and data-center energy.
No named guests; episode is a “TNB Tech Minute” hosted by Julie Chang (The Wall Street Journal) with sponsorship by Anthropic (Claude).
Oracle signed an uncancellable lease to support OpenAI, committed to pay rent even without power; after opposition, it dropped gas turbines/diesel generators and struggled to get state air permits; officials rejected parts of a 17-mile natural gas pipeline twice; Oracle removed a key land/power partner, though it says “Project Jupiter” remains on track.
Novo Nordisk paying up to $1.3B to license Nenexa’s PharmaShell (ultra-thin coating for controlled, sustained release) to reduce injection frequency for obesity/diabetes drugs. VCs investing $31B this year into energy/data-center firms.
Written by AI. May contain mistakes.
Discussion on the issues Oracle faces with its AI data center project.
“I'm Julie Chang for The Wall Street Journal.”

Get the gist, explore an idea or ask about something said.
On WSJ Tech News Briefing, what are the key points of this episode?
Automatic transcript. May contain errors.
0:00This episode is supported by Anthropic, the team behind Claude. Every business wants to move faster. Few can afford to be wrong. That's why the brands you trust also trust Claude. Here's your morning TNB Tech Minute for Friday, September 25th. I'm Julie Chang for The Wall Street Journal. Oracle's New Mexico AI Data Center project is facing challenges over power supply, permitting, and local resistance. People with knowledge of the deal say Oracle signed an uncancellable lease for an AI data center campus in New Mexico to support OpenAI, committing to pay rent even without power. But following community opposition, Oracle dropped plans for gas turbines and diesel generators and has struggled with state air permits.
0:46State officials also twice rejected part of a planned 17-mile natural gas pipeline, and sources say Oracle removed a key land and power partner. A spokesman for the company said Project Jupiter remains on track. Novo Nordisk agreed to pay up to$1.3 billion to license and develop Nenexa's drug delivery technology. The exclusive deal covers Nenexa's PharmaShell technology, which could cut the frequency that patients need to inject obesity and diabetes drugs. The technology applies an ultra-thin coating to drug particles for controlled, sustained release. Novo will lead global development and commercialization.
1:28And climate tech venture investors are shifting their focus from climate change and decarbonization to AI and powering data centers. According to market intelligence company Currents, investments into energy and data center companies by climate tech venture and growth funds totaled $31 billion so far this year, accounting for more than two-thirds of all capital deployed by such investors. Five years ago, these sectors represented about a fifth of climate tech dollars. While criticized for high resource consumption and carbon emissions, VCs argue their involvement ensures AI expands sustainably.
2:07That's your TMB Tech Minute. Join us again this afternoon for more. See what's next at claude.ai slash wsj.
Plus: Novo Nordisk to pay up to $1.3 billion for Nanexa’s drug delivery technology. And climate-tech venture investors are shifting their focus from climate change and decarbonization to AI and data centers. Julie Chang hosts.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.